130065-61-1CCCC1(CCC)CCC2(CCN(CCCN(CC)CC)C2)CC1.Cl.ClMOUZYBYTICOTFQ-UHFFFAOYSA-NAtiprimod Dihydrochloride is the dihydrochloride salt form of atiprimod, an orally bioavailable small molecule belonging to the azaspirane class of cationic amphiphilic agents with anti-inflammatory, antineoplastic, and anti-angiogenic activities. Atiprimod inhibits the phosphorylation of signal transducer and activator of transcription 3 (STAT3) and AKT, blocking the signaling pathways of interleukin-6, vascular endothelial growth factor (VEGF) and downregulating the anti-apoptotic proteins Bcl-2, Bcl-XL, and Mcl-1. This results in the inhibition of cell proliferation, induction of cell cycle arrest, and apoptosis.
130065-61-1Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
UsesAtiprimod Dihydrochloride is a JAK2 inhibitor and is also a novel immunomodulator.
No reaction records under the current filter.
Loading…
DTXSID20156331CHEMBL3215883